Write Your Own Review
You're reviewing:CyPPA
Rate this item:

Biological Data

Biological description Selective KCa2.2 and KCa2.3 activator (EC50 values are 14 and 5.6 µM respectively). Displays little or no activity at KCa2.1 and KCa3.1 channels. Reduces dopaminergic neuron activity and inhibits dopamine release.

Solubility & Handling

Storage instructions +4°C
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >99%
Chemical name N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine
Molecular Weight 285.39
Chemical structure CyPPA  [73029-73-9] Chemical Structure
Molecular Formula C16H23N5
CAS Number 73029-73-9
PubChem identifier 909822
SMILES CC1=NC(N2N=C(C)C=C2C)=NC(NC3CCCCC3)=C1
InChiKey USEMRPYUFJNFQN-UHFFFAOYSA-N

References for CyPPA

References are publications that support the biological activity of the product
  • New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.

    Coleman N et al (2014) Mol Pharmacol 86(3) : 342-57.
  • CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate.

    Herrik KF et al (2012) Front Pharmacol 3 : 11
  • Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+-activated K+ channels.

    Hougaard C et al (2007) Br J Pharmacol 151(5) : 655-65.

3 Item(s)